(10-069) Impact of Dalbavancin on 30-Day Hospital Readmission Rates in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Wednesday, December 10, 2025

11:00 AM - 12:00 PM

Location: Bayside A, Level 1

Residency Program: Blessing Hospital
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: Illinois

Co-Author(s): Williams Brandon, Kayla Fletcher, kara Mote, Ryan Thurm

Primary Author(s)